Navigation Links
d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug

(PRWEB) March 24, 2013

Approved by the FDA in April 2005, Byetta is a type-2 diabetes drug used to control glucose levels. Adverse Events, an organization that standardizes FDA adverse event reports, has processed 38,730 adverse events concerning Byetta and 1,733 of these reports allege a link between the drug and cases of pancreatitis (i). According to the USA Today article, “Popular diabetes drugs may raise pancreatic cancer risk, study suggests,” pancreatitis and cancer were two of the health concerns raised by a recent medical study (ii). The article goes on to report a study completed by the Research Center at the University of California, Los Angeles that found a six-fold increase of pancreatitis in patients taking Byetta or Januvia and it also increased the risk of pancreatic cancer by 2.9 times and thyroid cancer in patients taking the drug (ii).

Bloomberg reported the results of a Byetta medical study published in the Journal of the American Medical Association for Internal Medicine; the study followed 1,269 patients with type-2 diabetes who filled at least one prescription for a diabetes drug in a three-year period (iii). Out of the 145 patients who developed pancreatitis, 87 of them were taking Byetta or Januvia, the study suggested that Byetta and Januvia doubled the risk of pancreatitis compared to other diabetes drugs (iii). The study’s author, Dr. Sonal Singh, told Bloomberg that, “we really need to know more about these drugs as pancreatitis is on the pathway to pancreatic cancer (iii).”

The Byetta infographic provides a timeline detailing major events in the development of the drug. For example, from April 2005 until October 2008, the FDA received 78 complaints of kidney damage in patients using Byetta, 62 of these complaints reported kidney failure (iv). Visit the Byetta section of d’Oliveira & Associates or view the infographic HERE.

If you or a loved one has suffered pancreatic, liver, or thyroid cancer, after taking Byetta, you may want to speak with a personal injury lawyer. A dangerous drug lawyer familiar with the diabetes injection can investigate a legal claim. d’Oliveira & Associates is working with some of the most experienced Byetta lawyers in the country, who are handling these cases. And, there is no fee until you receive a Byetta settlement or award.

Please contact the law offices of d'Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. d'Oliveira & Associates Offers “No Win - No Fee Promise” on Topamax Cases
2. d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees
3. d'Oliveira & Associates Helps Massachusetts Man Receive $100,000 in Auto Accident Settlement
4. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Mirena IUD Cases
5. d'Oliveira & Associates Releases Fresenius Infographic about the FDA Recall of NaturaLyte and GranuFlo
6. D'Oliveira & Associates Now Offers a No Win No Fee Promise in Zithromax Cases
7. d'Oliveira & Associates Helps Fall River, MA Teenager Receive $38,500 in Auto Accident Settlement
8. d'Oliveira & Associates Notes the Announcement of Zoloft Birth Defects Multidistrict Litigation (MDL) Set to Start in Mid-September 2014
9. The Law Firm of d'Oliveira and Associates Now Offers a No Win - No Free Promise in Nexium Cases
10. The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Fosamax Cases
11. d'Oliveira & Associates Helps Newport Woman Receive $150,000 Settlement for Auto Accident; Case: MI-11889
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, ... editors can give their videos a whole new perspective by using the title ... Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to choose ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 /PRNewswire/ ... Diabetes Tomorrow,s Leaders Scholarship is any indication, the future ... today online at by the Diabetes ... stand in the way of academic and community service ... scholarship program since 2012, and continues to advocate for ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: